Trial Profile
Randomised Single Dose 3 Way Crossover Single Blind Study to Evaluate the Pharmacokinetic Dose Proportionality, Compare the Bioavailability and Safety of Clonidine Mucoadhesive Buccal Tablets (MBT) With Catapres in Normal Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Dec 2023
Price :
$35
*
At a glance
- Drugs Clonidine (Primary) ; Clonidine
- Indications Stomatitis
- Focus Pharmacokinetics
- Sponsors Onxeo SA; Valerio Therapeutics
- 19 Jul 2017 Results published in the Advances in Therapy
- 11 Oct 2016 Results of this study, presented at the 41st European Society for Medical Oncology Congress.
- 15 Apr 2016 Status changed from recruiting to completed.